Translating Evidence to Clinical Practice to Improve Outcomes in Patients with Small Cell Lung Cancer - Episode 4

Translating Evidence to Clinical Practice to Improve Outcomes in Patients with Small Cell Lung Cancer

In a recent OncLive® Scientific Interchange moderated by David R. Gandara, MD, experts discussed the prevalence and pathobiology of SCLC cases in their practices; the role of surgery, radiation, prophylactic cranial irradiation (PCI), and systemic therapy in LS-SCLC; and optimal systemic approaches for ES-SCLC in the first-line and relapsed settings.

EP. 1: Dr. Melosky on the Use of Lurbinectedin in SCLC
EP. 2: Dr. Bazhenova on the Challenges of Second-Line Therapy in SCLC
EP. 3: Dr. Florez (Duma) on Nihilism in SCLC
Now Viewing
EP. 4: Translating Evidence to Clinical Practice to Improve Outcomes in Patients with Small Cell Lung Cancer

Related Content:

Translating Evidence to Clinical Practice to Improve Outcomes in Patients with Small Cell Lung Cancer
Dr. Florez (Duma) on Nihilism in SCLC
Dr. Bazhenova on the Challenges of Second-Line Therapy in SCLC
Dr. Melosky on the Use of Lurbinectedin in SCLC